Systemic inflammation has been recognized as an extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD). Recent studies have indicated that exercise training can reduce the levels of inflammatory cells and mediators in both healthy individuals and those with heart diseases. However, the impact of combining resistance training (RT) with aerobic training (AT) on inflammatory biomarkers in COPD patients remains unclear. This study aims to analyze the effects of adding RT to AT on inflammatory markers in patients with COPD. Thirty-one patients diagnosed with COPD were randomly assigned to either a combined resistance and aerobic training group (RATG; n = 16) or an aerobic training group (ATG; n = 15). Both groups participated in their respective exercise regimens three times per week for a duration of 3 months. Anthropometric characteristics were recorded, and all patients underwent lung function testing as well as a six-minute walk test. Additionally, levels of IL-6, IL-17, and IL-32 were measured to assess inflammation. The 6-min walking distance, dyspnea levels, and oxygen saturation (SpO2) all showed significant improvement in the intervention group. In both groups, the concentrations of IL-6, IL-17, and IL-32 decreased significantly (p < .05) following the rehabilitation program. Notably, IL-6 levels exhibited a more significant decrease in the intervention group compared to the control group. Both exercise regimens led to reductions in IL-6, IL-17, and IL-32 levels. However, the combined training appears to exert a synergistic effect, potentially offering greater anti-inflammatory and functional benefits in COPD patients.
Effects of Combined Resistance and Aerobic Training on the Inflammatory Markers in Male Patients With COPD: A Randomized Controlled Trial / A. Acheche, M. Tounsi, M. Mekki, G. Racil, O. Tabka, S. Bchir, H. Ben Nasr, K. Chahed, J. Padulo, G.M. Migliaccio, Y. Trabelsi. - In: RESEARCH QUARTERLY FOR EXERCISE AND SPORT. - ISSN 0270-1367. - (2025), pp. 1-9. [Epub ahead of print] [10.1080/02701367.2025.2535476]
Effects of Combined Resistance and Aerobic Training on the Inflammatory Markers in Male Patients With COPD: A Randomized Controlled Trial
J. Padulo
;
2025
Abstract
Systemic inflammation has been recognized as an extrapulmonary manifestation of chronic obstructive pulmonary disease (COPD). Recent studies have indicated that exercise training can reduce the levels of inflammatory cells and mediators in both healthy individuals and those with heart diseases. However, the impact of combining resistance training (RT) with aerobic training (AT) on inflammatory biomarkers in COPD patients remains unclear. This study aims to analyze the effects of adding RT to AT on inflammatory markers in patients with COPD. Thirty-one patients diagnosed with COPD were randomly assigned to either a combined resistance and aerobic training group (RATG; n = 16) or an aerobic training group (ATG; n = 15). Both groups participated in their respective exercise regimens three times per week for a duration of 3 months. Anthropometric characteristics were recorded, and all patients underwent lung function testing as well as a six-minute walk test. Additionally, levels of IL-6, IL-17, and IL-32 were measured to assess inflammation. The 6-min walking distance, dyspnea levels, and oxygen saturation (SpO2) all showed significant improvement in the intervention group. In both groups, the concentrations of IL-6, IL-17, and IL-32 decreased significantly (p < .05) following the rehabilitation program. Notably, IL-6 levels exhibited a more significant decrease in the intervention group compared to the control group. Both exercise regimens led to reductions in IL-6, IL-17, and IL-32 levels. However, the combined training appears to exert a synergistic effect, potentially offering greater anti-inflammatory and functional benefits in COPD patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
Acheche RQES 2025 Effects of Combined Resistance and Aerobic Training on the Inflammatory Markers in Male Patients With COPD A Randomized Controlled Trial.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
1.98 MB
Formato
Adobe PDF
|
1.98 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




